Music Therapy in Obsessive Compulsive Disorder

NCT02314195 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-12-11

No results posted yet for this study

Summary

Previous studies have highlighted the potential therapeutic benefits of receptive individual music therapy as an adjunct to standard care, in a variety of psychiatric ailments including mood and anxiety disorders. However, the role of music in the treatment of obsessive compulsive disorder have not been investigated to date. The present study therefore aimed to investigate the efficacy of music therapy as an adjunct to standard treatment, on obsessions in patients with treatment-naïve OCD. Moreover, given the fact that a significant proportion of patients with OCD have other comorbid mood or anxiety disorders, the question of whether therapeutic benefits of music could be expanded to also affect concurrent depressive and anxiety symptoms was explored.

Conditions

Interventions

DRUG

Selective serotonin re-uptake inhibitor

A medication of selective serotonin re-uptake inhibitor (SSRI) family, Behavioral. The type and dosage of the medication was decided by the treating psychiatrist.

BEHAVIORAL

Cognitive Behavioral Therapy

Cognitive Behavioral Therapy for obsessive compulsive disorder carried out by a psychologist.

OTHER

Music therapy

12 sessions of 30-minute individual-based receptive music therapy, supervised by the treating psychiatrist.

Sponsors & Collaborators

  • Islamic Azad University, Marvdasht

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-06-30
Completion
2014-08-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02314195 on ClinicalTrials.gov